CD8A and COVID-19: In the virus-challenge experiment using rhesus macaques, depletion of CD8+ T cells in convalescent macaques that had been infected with SARS-CoV-2 partially abrogated the protective efficacy of natural immunity against rechallenge with SARS-CoV-2 (27), suggesting CD8+ T cells can contribute to virus control in COVID-19.